Kathleen M. Powers N.P., Michael J. Wilkowski M.D., Allen W. Helmandollar, Karl G. Koenig M.D., W. Kline Bolton M.D. Division of Nephrology, University of Virginia Health Sciences Center, Charlottesville, Virginia, 22908 USA Kathleen M. Powers, R.N., N.P. Nephrology Nurse Practitioner Division of Nephrology, Box 133 University of Virginia Health Sciences
Visit this article presented by the National Kidney and Urologic Disease Information Clearinghouse for more information on how URR and Kt/V are used to assess dialysis adequacy in general use. Read Now
Improving Adequacy of Dialysis: Using In-Series Dialyzers Read Now
Abstract Background: Dialysis adequacy targets frequently are difficult to achieve in large hemodialysis patients. Dual dialyzers can be used to improve clearance. It is unknown whether series or parallel configurations are superior. Methods: Eighteen large hemodialysis patients (mean weight, 92.4 kg) were enrolled in a randomized, crossover trial to directly compare
Tri-Counties Dialysis Center in Decatur, Ind., is a freestanding, for-profit hemodialysis facility operated by Everest Healthcare Services. The facility opened in the spring of 1996. The patient population consists primarily of elderly patients who live in the surrounding countryside and small towns of northeastern Indiana. The facility population has been
Abstract Convective therapies such as hemofiltration, hemodiafiltration and double high flux dialysis have been shown to improve treatment delivered and treatment tolerance when compared to conventional dialysis therapies. The risk associated with these treatments is primarily in the quality of the substitution fluid. Technological advances now permit online-produced substitution fluid, thereby
On August 14, 2000, the U.S. Food and Drug Administration released its final guidance on the practice of reusing medical devices that are intended to be used only once. In the guidance, titled “Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals” (http://www.fda.gov/cdrh/comp/guidance/1168.pdf), FDA states that it will
Joan Camarro Simard, Department Editor Case Study from the December 1999 issue of the ANNA Journal Hazel A. Dennison Patient Profile W.T., a 43-year-old male, began on hemodialysis in 1996 for membranoproliferative glomerulonephritis (MPGN). His height was 5’10” and his weight was 330 lbs. He supported his wife and 3
Philip Andrysiak, BS, MBA, CHT Recent incidents of blood contamination of the internal pressure monitoring lines have raised concerns with respect to cross-contamination and patient safety. The MPC-75 moves the redundant transducer protector from the inside of the machine to the outside where it can be visually inspected for primary
All Molded Products, Inc., products are registered with the U.S. Food and Drug Administration (FDA) as Class I and Class II medical devices. Devices are classified according to the degree of difficulty or level of control necessary to provide reasonable assurance of its safety and effectiveness. Devices must be sold under conditions specified by regulatory controls.
